Factoid—Ron Renaud has been CEO of three biotech companies acquired by Big Pharma during the past decade: CERE (2023), TBIO (2021), and IDIX (2014). The buyers were ABBV, SNY, and MRK, respectively.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”